Showing 1,161 - 1,180 results of 1,890 for search '"Type 2 diabetes"', query time: 0.25s Refine Results
  1. 1161

    Relationship between nerve ultrasonography image and electrophysiology in diabetic polyneuropathy by Pei‐Chen Hsieh, Long‐Sun Ro, Chun‐Che Chu, Ming‐Feng Liao, Hong‐Shiu Chang, Hung‐Chou Kuo

    Published 2025-02-01
    “…ABSTRACT Aims/Introduction This study aims to investigate the association between cross‐sectional area (CSA) imaging findings of nerve ultrasound and conventional nerve conduction studies (NCS) for patients with distal symmetric sensorimotor polyneuropathy (DSPN) due to type 2 diabetes mellitus. Materials and Methods We enrolled 103 patients with type 2 diabetes mellitus and collected their demographic data, modified Michigan Neuropathy Screening Instrument (mMNSI) score, NCS, and ultrasonography images of peripheral nerves. …”
    Get full text
    Article
  2. 1162

    Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study by Yoshiya Tanaka, Yosuke Okada, Tetsuya Kawahara, Gen Suzuki, Tetsuya Inazu, Shoichi Mizuno, Fumiyoshi Kasagi

    Published 2016-07-01
    “…The primary end point is the cumulative incidence of type 2 diabetes. Secondary endpoint is the number of participants who achieve normoglycaemia at 48, 96 and 144 weeks. …”
    Get full text
    Article
  3. 1163

    A Cross-Sectional Study to Assess Diabetes as a Risk Factor for Root Caries Amongst the Elderly Population in Udupi District, Karnataka State, India by Kush Kalra, Ramprasad Vasthare, Shivashankar K. N., Nishu Singla, Deepak Kumar Singhal, Ritesh Singla

    Published 2024-01-01
    “…Participants with type 2 diabetes, less education, low socioeconomic status, and using finger cleaning had a significantly higher risk of developing root caries. …”
    Get full text
    Article
  4. 1164

    New Players for Advanced Prostate Cancer and the Rationalisation of Insulin-Sensitising Medication by Jennifer H. Gunter, Phoebe L. Sarkar, Amy A. Lubik, Colleen C. Nelson

    Published 2013-01-01
    “…Obesity and type 2 diabetes are recognised risk factors for the development of some cancers and, increasingly, predict more aggressive disease, treatment failure, and cancer-specific mortality. …”
    Get full text
    Article
  5. 1165

    The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes w... by Rehana Akter, Alexander Zhyvoloup, Bingqian Zheng, Surita R Bhatia, Daniel P Raleigh

    Published 2019-01-01
    “…The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure. The Alzheimer's Aβ peptide and human amylin (h-amylin), the polypeptide responsible for amyloid formation in type-2 diabetes, share common physio-chemical features and some inhibitors of Aβ also inhibit amyloid formation by h-amylin and vice versa. …”
    Get full text
    Article
  6. 1166

    Molecular Exercise Physiology : an introduction /

    Published 2014
    View in OPAC
    Book
  7. 1167

    Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus-Induced Insulin Resistance by Francesco Negro

    Published 2009-01-01
    “…Insulin resistance and type 2 diabetes are associated with hepatitis C virus infection. …”
    Get full text
    Article
  8. 1168

    Brevibacterium Bacteremia in the Setting of Pyogenic Liver Abscess: A Case Report with Accompanying Literature Review by Sarah Hossain, Afif Hossain, Aldo Barajas-Ochoa, Michael A. Jaker

    Published 2021-01-01
    “…A 71-year-old Pakistani man with poorly controlled type 2 diabetes mellitus presenting with worsening mental status, abdominal pain, and oral intake for the past seven days was found to have pyogenic hepatic abscess with unculturable bacteria and subsequently found to have rare Brevibacterium bacteremia.…”
    Get full text
    Article
  9. 1169

    Living with Diabetes by Nancy J. Gal, Linda B. Bobroff

    Published 2012-08-01
    “…Although there is no cure for type 1 or type 2 diabetes, diabetes can be managed with the proper care. …”
    Get full text
    Article
  10. 1170

    Symptoms of Diabetes by Linda B. Bobroff

    Published 2013-07-01
    “…Type 2 diabetes is a growing health concern for children and adults in the United States. …”
    Get full text
    Article
  11. 1171

    Living with Diabetes by Nancy J. Gal, Linda B. Bobroff

    Published 2012-08-01
    “…Although there is no cure for type 1 or type 2 diabetes, diabetes can be managed with the proper care. …”
    Get full text
    Article
  12. 1172

    Predictive Ability of Visit-to-Visit Variability of HbA1c Measurements for the Development of Diabetic Kidney Disease: A Retrospective Longitudinal Observational Study by Yunyi Yan, Nozomi Kondo, Kentaro Oniki, Hiroshi Watanabe, Tadashi Imafuku, Yuki Sakamoto, Takuro Shigaki, Akari Maruyama, Hitomi Nakazawa, Tetsuya Kaneko, Ayami Morita, Akira Yoshida, Hitoshi Maeda, Toru Maruyama, Hideaki Jinnouchi, Junji Saruwatari

    Published 2022-01-01
    “…Visit-to-visit variability of HbA1c was an independent risk factor of microalbuminuria in association with oxidative stress among type 2 diabetes mellitus patients. HbA1c-AUC, a novel index of HbA1c variability, may be a potent prognostic indicator in predicting the risk of microalbuminuria.…”
    Get full text
    Article
  13. 1173

    Characterization of Stroke Patients in an Intensive Care Unit by Marianela Planes Fajardo, Georgia Díaz-Perera Fernández, Maylín Isabel Alonso Martínez, Aurora Calzada Fajardo

    Published 2021-06-01
    “…<br /><strong>Conclusions:</strong> the risk factors with the highest frequency were: smoking, type 2 diabetes mellitus and age over 60 years old.…”
    Get full text
    Article
  14. 1174

    Cohort profile: Health in Central Denmark (HICD) cohort - a register-based questionnaire survey on diabetes and related complications in the Central Denmark Region by Annelli Sandbæk, Else-Marie Dalsgaard, Kasper Norman, Lasse Bjerg, Anders Aasted Isaksen

    Published 2022-07-01
    “…Among these respondents, 2,832 persons had type 1 diabetes (55.9%), 21,140 persons had type 2 diabetes (53.2%), while 27,892 persons were part of the matched group without diabetes (60.4%). …”
    Get full text
    Article
  15. 1175

    Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review by Aleksander Jentkiewicz, Esmail Haj Obeid, Jakub Ulrych, Jan Krupa, Maciej Malinowski, Michał Krasowski, Alicja Kalinowska, Wiktoria Pietras, Adrian Kozieł, Zofia Kurek

    Published 2025-02-01
    “…Introduction and Purpose: Obesity is an escalating global health challenge, affecting over 2 billion individuals worldwide, contributing to many challenges for healthcare providers such as cardiovascular disorders, cancers, and type 2 diabetes mellitus. There is a need for effective treatments targeting T2DM, and obesity. …”
    Get full text
    Article
  16. 1176

    The Effect of Prior Gestational Diabetes on the Shape of the Glucose Response Curve during an Oral Glucose Tolerance Test 3 Years after Delivery by Timea Tänczer, Márk M. Svébis, Beatrix Domján, Viktor J. Horváth, Adam G. Tabák

    Published 2020-01-01
    “…Monophasic glucose response (MGR) during an oral glucose tolerance test (OGTT) and gestational diabetes mellitus (GDM) are predictors of type 2 diabetes mellitus (T2DM). We investigated the association between current MGR and (1) glucose tolerance during a pregnancy 3 years before and (2) current glucose tolerance status. …”
    Get full text
    Article
  17. 1177
  18. 1178

    Habitual sleep duration, healthy eating, and digestive system cancer mortality by Diana A. Nôga, Elisa M. S. Meth, André P. Pacheco, Jonathan Cedernaes, Pei Xue, Christian Benedict

    Published 2025-01-01
    “…Adjusting for smoking, type 2 diabetes, and body mass index (BMI) status eliminated the association between sleep duration and digestive cancer mortality. …”
    Get full text
    Article
  19. 1179

    An Exceedingly Rare Case of Liraglutide-Induced Liver Injury by Swetha Parvataneni, Rajarajeshwari Ramachandran, Eric Then, Tyler Grantham, Vinaya Gaduputi

    Published 2021-01-01
    “…Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.…”
    Get full text
    Article
  20. 1180

    Adding Value to Milk by Increasing Its Conjugated Linoleic Acid Content by Lokenga Badinga, Richard D. Miles

    Published 2011-07-01
    “…In laboratory animals, this naturally occurring fatty acid has been shown to inhibit cancer, promote the immune system, reduce the effect of type 2 diabetes, promote bone growth, and reduce blood clotting. …”
    Get full text
    Article